The short answer
A small set of terms recurs throughout peptide literature, residue, terminus, amidation, analogue, fragment, agonist, secretagogue. Each has a precise meaning, and several are used loosely in commercial writing in ways that change what is being claimed.
Key facts
- Residue
- An amino acid within a chain
- N-terminus
- The free-amine end
- C-terminus
- The carboxyl end
- Amidation
- C-terminal COOH replaced by CONH2
- Analogue
- Modified version of a parent
- Fragment
- A piece of a larger sequence
- Agonist
- Activates a receptor
The counting prefixes
Peptides are frequently named by length in Greek numerals, tripeptide, pentapeptide, heptapeptide, nonapeptide, pentadecapeptide for fifteen. Seeing pentadecapeptide in a paper title tells you the molecule's size before you read anything else, which is why the convention persists.
Analogue versus fragment
These are different and are often conflated. An analogue is a modified version of a parent molecule. Semaglutide is a GLP-1 analogue, with substitutions and a lipid chain. A fragment is a piece of a larger sequence, unmodified but incomplete. TB-500 is a fragment of thymosin beta-4. A molecule can be both: Modified GRF (1-29) is a fragment of GHRH that is also an analogue of that fragment.
Research material referenced
BPC-157 5mg, third-party HPLC tested
Why amidation is not cosmetic
Replacing a C-terminal carboxyl with an amide removes a negative charge and blocks carboxypeptidase attack. Many natural peptide hormones are amidated, so reproducing it in an analogue preserves both the native electrostatics and that protection. It also adds roughly 1 Da less than an unmodified terminus would give, which matters when checking a mass.
Agonist, antagonist and secretagogue
An agonist activates a receptor. An antagonist blocks it. A secretagogue prompts a gland to release something it already makes, which is a different kind of intervention from supplying the substance directly. The GIP paradox in the incretin literature (where an agonist and an antagonist both produce weight reduction) is a reminder that these labels describe mechanism rather than outcome.
Non-standard residues
Aib is α-aminoisobutyric acid, used to block peptidase access. D-amino acids are mirror images of the natural L forms and resist proteases that evolved for L backbones. Both appear in engineered peptides (ipamorelin contains one Aib and two D-residues) and neither can be written in single-letter code, which is itself a signal that a sequence is designed rather than natural.
Terms that carry a claim
Some names assert a function: body protection compound, delta sleep-inducing peptide, liver cell growth factor. These record what an investigator believed at discovery. They are hypotheses embedded in labels, and reading them as descriptions is the most common way a claim enters someone's thinking without ever being evaluated.
Frequently asked questions
What is the difference between an analogue and a fragment?
An analogue is a modified version of a parent; a fragment is an unmodified piece of a larger sequence. A molecule can be both.
Why are some peptides amidated?
It removes a C-terminal negative charge and blocks carboxypeptidase attack. Many natural peptide hormones are amidated.
What is a secretagogue?
A compound prompting a gland to release something it already produces, rather than supplying that substance directly.
Continue researching
Peer-reviewed guides, comparators and matched reference materials.
Primary sources & clinical trials
Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.
- PubMedJaradat DMM, Thirteen decades of peptide synthesis. Amino Acids 2018 (PMID 29185032)pubmed.ncbi.nlm.nih.gov
- PubChemPubChem: compound databasepubchem.ncbi.nlm.nih.gov
- StandardICH Q2(R1) · Validation of Analytical Procedures (HPLC)ich.org
- StandardUSP <1121> · Nomenclature and USP <621> Chromatographyusp.org
- PubMedNail SL et al., Fundamentals of freeze-drying. Pharm Biotechnol 2002 (PMID 12189727)pubmed.ncbi.nlm.nih.gov
- PubMedManning et al., Stability of protein pharmaceuticals. Pharm Res 2010 (PMID 20143256)pubmed.ncbi.nlm.nih.gov
- FDAFDA · Search Guidance Documents. peptide drug product CMC guidancefda.gov
- EMAEMA · Guideline on development & manufacture of synthetic peptidesema.europa.eu
- GuidelineGoogle: Creating helpful, reliable, people-first contentdevelopers.google.com
Browse the wider literature
Live database searches, not fixed citations. Results change as new work is indexed.
Written and reviewed by
William Heath · Editor, UK Peptides research library
William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.
More Peptide Reference articles
- Oligopeptide, Polypeptide, ProteinThree terms describing the same kind of molecule at different lengths. Where each is conventionally applied and why none of the boundaries is chemical.
- Research Peptides and Collagen Peptides ComparedOne is a defined synthetic sequence; the other is an undefined mixture from hydrolysed protein. Same word, entirely different categories of material.
- Net Peptide Content: The Number That Says How Much You HaveA vial labelled 10mg does not contain 10mg of peptide. Water, counter-ions and salts make up the difference, and only one figure tells you how much.
- The Method That Measures Peptide DirectlyHydrolyse the peptide to free amino acids, quantify them against standards. Why it is the reference method, and which residues it cannot recover.
- Aspartimide Formation and Why It HidesThe most serious side reaction in synthesising aspartate-containing peptides. It is sequence-dependent, and the product weighs the same as the target.